The Coronavirus Vaccine, cataloged under National Stock Number 6505-01-692-5287, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Moderna Us, Inc.. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BX.
| Parameter | Value |
|---|---|
| NSN | 6505-01-692-5287 |
| Primary Part Number | NDC80777-0273-99 |
| Item Name | Coronavirus Vaccine |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Moderna Us, Inc. |
| Status | ACTIVE |
| Administration | INJECTION |
| Primary Container Content Quantity | 5.0 MILLILITERS |
| Virus Strain | COVID-19 |
| Primary Container Type | VIAL, GLASS |
| Total Primary Container Quantity | 10 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BX |
| Part Number | Manufacturer |
|---|---|
| MODERNA C19 VAC | Moderna Biotech Spain SL. (ESP) |
| EU/1/20/1507/001 | Moderna Biotech Spain SL. (ESP) |
| NDC80777-0273-99 PRIMARY | Moderna Us, Inc. (USA) |
| Reference | Meaning |
|---|---|
| 6505PL1998660 | 6/9 Informative reference only Jednolity Indeks Materialowy - Uniform Material Index |
| 1585863 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM206711 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-692-5287 is a Coronavirus Vaccine, manufactured by Moderna Us, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-692-5287 has 3 manufacturer part numbers on file: MODERNA C19 VAC (Moderna Biotech Spain SL.), EU/1/20/1507/001 (Moderna Biotech Spain SL.), NDC80777-0273-99 (Moderna Us, Inc.).
Key specifications for NDC80777-0273-99: Administration: INJECTION; Primary Container Content Quantity: 5.0 MILLILITERS; Virus Strain: COVID-19; Primary Container Type: VIAL, GLASS. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.